CMS launches Medicare Coverage Gap Discount Program
January 11th 2011A key provision of the Affordable Care Act kicked in January 1 when Medicare beneficiaries who have Part D but don?t get the low-income subsidy ?Extra Help? began receiving a 50% discount under the Medicare Coverage Gap Discount Program on applicable drugs at point of sale. The following article explains how pharmacies should prepare.
Many new cancer drugs require updated safety labels
January 11th 2011Many serious or potentially fatal adverse reactions associated with new, targeted anti-cancer agents are not reported in the original published research on the drug, and they are not known to oncologists until years later when drug labels are updated, including boxed warnings, according to research published online in the Journal of Clinical Oncology, HealthDay News reported.
Combining statins and fibrates increases rhabdomyolysis risk
January 6th 2011Patients who are newly treated with statin-fibrate concurrent therapy are slightly more likely to be hospitalized with rhabdomyolysis than those who take just one of the medications, according to research published in the American Journal of Cardiology, HealthDay News reported.
Many new cancer drugs require updated safety labels
January 6th 2011Many serious or potentially fatal adverse reactions associated with new, targeted anti-cancer agents are not reported in the original published research on the drug, and they are not known to oncologists until years later when drug labels are updated, including boxed warnings, according to research published online in the Journal of Clinical Oncology, HealthDay News reported.
Study finds dosing and directions for pediatric liquid OTC medications inconsistent
January 6th 2011The directions and devices provided with OTC liquid medicines for kids are often inconsistent and confusing for parents to follow, according to a study published in the Journal of the American Medical Association.
Drop FFS, Save $30 billion on Medicaid
January 6th 2011State Medicaid programs could save $30 billion over the next decade by replacing fee for service pharmacy programs with managed care programs like those used in Medicare Part D, according to a new report on Medicaid pharmacy spending sponsored by the Pharmaceutical Care Management Association.
ARB-based therapy does not reduce mortality in setting of diabetes and hypertension
December 30th 2010Antihypertensive therapy with an ARB is not associated with reductions in cardiovascular or all-cause mortality compared to non-ARB-based regimens in patients with type 2 diabetes, according to researchers at the Massachusetts College of Pharmacy and Health Sciences.
Rural teens more likely to abuse prescription drugs than their urban, suburban counterparts
December 28th 2010Adolescents living in rural areas are significantly more likely to abuse prescription drugs than their counterparts in urban areas, according to a study published online November 1 in the Archives of Pediatrics & Adolescent Medicine, HealthDay News reported.
Paricalcitol found to reduce albuminuria in type 2 diabetes
December 28th 2010In a multi-national, placebo-controlled, double-blind trial, the selective vitamin D receptor activator paricalcitol (Zemplar, Abbott Laboratories), at doses of 1 µg or 2 µg daily, can reduce albuminuria in patients with type 2 diabetes, who were already being treated with renin-angiotensin-aldosterone system inhibitors.
Metformin may lower mortality in heart failure patients
December 28th 2010In research published in the October 1 issue of the American Journal of Cardiology, HealthDay News reported, metformin, either alone or in combination with sulfonylurea, appears to increase 1-year and long-term survival in patients with T2DM and CHF.
Patients rarely remain on varenicline in effort to quit smoking
December 23rd 2010"Few patients who are prescribed varenicline to assist in smoking cessation remain on the therapy, according to retrospective data presented during the 45th midyear meeting of the American Society of Health Systems Pharmacists."
No safety issues observed with combination treatment for recurrent herpes simplex labialis
December 23rd 2010Treatment of recurrent herpes simplex labialis with combination 5% acyclovir and 1% hydrocortisone cream is safe in adolescents. In a study of a 5-day treatment course, no safety concerns were identified, said Anders Strand, MD, PhD, at the 45th midyear meeting of the American Society of Health Systems Pharmacists.
Combination improves tumor response rates in patients with HER2-positive breast cancers
December 23rd 2010A combination of lapatinib, trastuzumab, and paclitaxel significantly improved tumor response rates in patients with HER2-positive breast cancers, according to a new study presented at the San Antonio Breast Cancer Symposium held recently in San Antonio, Texas.
Unproven treatments are overused to treat neck pain
December 21st 2010Diagnostic testing, narcotics, and questionable treatment modalities appear to be overused for chronic neck pain, while effective treatments such as therapeutic exercise appear to be underused, according to a study in the November issue of Arthritis Care & Research, HealthDay News reported.
Safe Use Initiative report summarizes views to promote patient medication safety
December 21st 2010A recently released Institute of Medicine workshop summary indicates there are myriad ideas, including better use of EMRs and research to focus action on the most common elements associated with adverse events.